In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Scientific acquires the remainder of Rubicon Medical

Executive Summary

Boston Scientific has exercised its option under a 2003 agreement to acquire the Rubicon Medical (interventional vascular medical devices) shares held by its principal stockholders (chairman David Berger and president and CEO Richard Linder), giving it a 53.6% stake in the company. BS has also agreed to purchase any other remaining outstanding shares; altogether it will pay $71.7mm in cash, with the potential of another $83.7mm in milestone-based earn-outs.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies